547P Rucaparib + sacituzumab govitecan (SG): Initial data from the phase Ib/II SEASTAR study (NCT03992131)
Authors:
- T.A. YapTYT.A. Yap
- E.P. HamiltonEHE.P. Hamilton
- T.M. BauerTBT.M. Bauer
- E.E. Ileana DumbravaEDE.E. Ileana Dumbrava
- R. JeselsohnRJR. Jeselsohn
- A. EnkeAEA. Enke
- S. HurleySHS. Hurley
- K.K. LinKLK.K. Lin
- K. WrideKWK. Wride
- H. GiordanoHGH. Giordano
- G. ShapiroGSG. Shapiro
- 1 September 2020
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 31, S476-S477